Iruksol ointment
 Iruksol - dermotropic antimicrobial external agent for the treatment of persistent wounds of various etiologies.

Pharmacological action

Iruksol - combined preparation, which includes the antibiotic chloramphenicol and enzyme klostridilpentidaza.

It is the presence of enzymes in the product allows you to quickly achieve cleansing of necrotic tissue, which are full of microbes in the treatment of purulent wounds and venous ulcers.

Active ingredients Iruksola have antibacterial, antimicrobial, wound healing and ranoochischayuschim action.

It prevents the development of infection, favors epithelialization, granulation and helps cleanse wounds and accelerates regeneration.

A distinctive feature of Iruksola other antibacterial ointment is the ability to clean almost any wound etiology, the ability to remove necrotic tissue and small crusts without mechanical intervention, and mitigation of large areas of skin exposed necrotic lesions.

In the opinion of Iruksole, cleansing effect felt from the very first days of application, therapeutic effect - during the first two weeks of the application, and in most cases, improvement occurs in the first week.

Product form

Iruksol manufactured as an ointment. 1 g contains 10 mg of chloramphenicol and 0, 6 units klostridilpeptidazy A. tubes of 30 g, in carton.

Indications Iruksola

 When gangrene of limbs used Iruksol
 Iruksol of instructions used in expressions and necrosis:

  • Diabetic gangrene and frostbitten limbs;
  • Varicose veins;
  • Gangrene of the extremities;
  • Bedsores;
  • Burns 2 and 3 degrees.

Also Iruksol ointment used in non-healing wounds is long - in radiation, post-surgical, traumatic injuries of soft tissues, as well as the preparation of the skin prior to transplantation.

In the opinion of Iruksol effective for the treatment of septic and necrotic complications of diabetic foot.


Iruksol of instruction is contraindicated in:

  • Individual intolerance of chloramphenicol and other components of the drug;
  • Certain blood disorders - hemolytic jaundice, panmielopatii, including a history;
  • Severe liver and kidney damage;
  • Psoriasis;
  • Fungal diseases of the skin.

Ointment Iruksol not indicated during pregnancy and lactation and children under 12 years of age due to lack of studies.

Instructions for use Iruksola

Iruksol Ointment is applied topically once daily about 2 mm thick. Wound surface must be pre-moistened. After the drug softened necrotic tissue must be removed when changing bandages.

Often, to avoid the possibility of irritation, the edges of the wound are applied zinc ointment.

Iruksol ointment is not recommended in conjunction with other topical medications, due to a possible decrease in the effectiveness Iruksola.

Side effects

In the opinion of Iruksol may cause some allergic reactions such as skin rash and contact dermatitis, pain and a burning sensation at the site of application and irritation.

Exact analogy in Iruksola not. Quite often, ointments based on hydrophilic - Levomekol, Levosin or Oflokain to accelerate the flow of the first phase of wound healing, as well as ointments and Noruksol Fermenkol. However, these drugs have a similar chemical composition and therapeutic effect, and are not Iruksola analogues.

Storage conditions

Iruksol available without a prescription. Shelf life - 5 years.